Top compounds associated with response to PANK1


Feature Type Standardized
Nominal ANOVA
mRNA alisertib CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.16 6e-07
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.2 7e-07
mRNA Topotecan CTRPv2 pan-cancer AAC 0.17 7e-07
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.19 8e-07
mRNA GW-405833 CTRPv2 pan-cancer AAC 0.18 8e-07
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.16 9e-07
Download CSV